John Montana

A medicinal chemist by training, John Montana brings over 30 years’ experience in drug discovery and early development across the pharmaceutical, biotech and contract research sectors. He joined Forbion from Charles River Labs (CRL) where he was Corporate Vice President, Integrated Drug Discovery in which he oversaw all aspects of partnered integrated drug discovery projects, ensuring their scientific progression from early business development discussions through to the delivery of quality clinical candidates.

Before joining CRL, John spent 10 years at Argenta initially as CSO and then Managing Director for the last 5 years. Within these roles John was responsible for the scientific strategy and operational direction and growth of the company and played a leading role in the sale of Argenta to Galapagos in 2010 and the subsequent sale of Argenta to CRL in 2014.